Product image of Levetiracetam Noridem (Levetiracetam) supplied by GNH India

Levetiracetam Noridem

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Noridem (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an antiepileptic presented as an intravenous solution for intravenous use. It is employed to manage various seizure types, including partial‑onset, myoclonic, and primary generalized tonic‑clonic seizures, in patients diagnosed with epilepsy. The formulation is designed for hospital settings where rapid control of seizures is required.

GNH India supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic medication that modulates neuronal excitability to treat seizure disorders.
  • Partial‑onset seizures: reduces seizure frequency and severity in focal epilepsy.
  • Myoclonic seizures: controls rapid, brief muscle jerks associated with juvenile myoclonic epilepsy.
  • Primary generalized tonic‑clonic seizures: helps prevent generalized convulsive episodes in patients with generalized epilepsy.
  • Adjunct therapy for refractory epilepsy: added to existing regimens when seizures are not adequately controlled.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction stabilizes neuronal membranes and reduces hyper‑excitability, thereby decreasing the likelihood of seizure propagation across neural networks.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness or drowsiness.
  • Headache: mild to moderate cranial pain.
  • Irritability: mood changes or increased agitation.
  • Nausea: feeling of stomach upset.

Serious or Rare Side Effects

  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Suicidal ideation: thoughts of self‑harm or depression.
  • Blood dyscrasias: including neutropenia or thrombocytopenia.
  • Severe depression: marked mood disturbances requiring medical attention.
  • Anaphylaxis: acute allergic reaction with respiratory compromise.
  • Respiratory depression: reduced breathing effort, especially with other CNS depressants.

Precautions & Warnings

  • Use of levetiracetam requires careful clinical consideration to minimize risks.
  • Renal impairment: adjust dosing or monitor renal function closely.
  • Hepatic impairment: use with caution and observe for altered metabolism.
  • Psychiatric symptoms: monitor patients for mood changes, irritability, or depression.
  • Concomitant CNS depressants: assess additive sedation and respiratory effects.
  • Pregnancy: risk unknown; discuss potential benefits and risks with a healthcare provider.
  • Store at below 25°C: keep in the original pack, protect from moisture and light.

Avoid Interactions

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma concentrations.
  • Enzyme‑inducing antiepileptics (phenytoin, phenobarbital): can decrease levetiracetam effectiveness.
  • Strong CYP3A4 inhibitors (ketoconazole): potential for increased levetiracetam exposure.

Moderate Interactions (Monitor Closely)

  • CNS depressants (benzodiazepines, alcohol): may enhance sedation.
  • Antidepressants (SSRIs): possible mood alterations.
  • Renally cleared drugs (acyclovir): monitor renal function for additive load.

Frequently Asked Questions

Levetiracetam Noridem is an intravenous antiepileptic used to treat partial‑onset seizures, myoclonic seizures, and primary generalized tonic‑clonic seizures in patients with epilepsy. It may also be employed as an add‑on therapy when seizures are not adequately controlled by other medications.

Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This binding modifies vesicle exocytosis, stabilising neuronal membranes and reducing excessive neuronal firing that can lead to seizure activity.

The appropriate dose of Levetiracetam Noridem is determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type and clinical response. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Healthcare providers should weigh potential benefits against possible risks and discuss options with the patient before use.

To order, submit an enquiry on the Levetiracetam Noridem product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Levetiracetam has a distinct mechanism (SV2A binding) and a relatively favorable drug‑interaction profile compared with enzyme‑inducing agents such as carbamazepine or phenytoin. It is often chosen for its rapid intravenous administration and minimal hepatic metabolism, though individual response and tolerability vary.

Store the product at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Avoid freezing the solution. Follow standard aseptic techniques when preparing the intravenous infusion.

Levetiracetam Noridem is administered by intravenous infusion under the supervision of qualified healthcare personnel. The infusion rate and volume are set according to the prescribing information and the patient’s clinical condition.

Serious adverse events include severe skin reactions (e.g., Stevens‑Johnson syndrome), suicidal thoughts or behavior, significant depression, blood dyscrasias, anaphylaxis, and respiratory depression, especially when combined with other central nervous system depressants.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid use. Caution is advised in individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT